Riccardo Asero Selected Research

Riccardo Asero Research Topics

Disease

31	Hypersensitivity (Allergy) 08/2022 - 02/2002
30	Chronic Urticaria 01/2022 - 05/2002
17	Urticaria (Hives) 05/2021 - 05/2002
11	Food Hypersensitivity (Food Allergy) 10/2022 - 05/2005
7	Seasonal Allergic Rhinitis (Hay Fever) 01/2021 - 02/2004
6	Angioedema 01/2017 - 05/2002
5	Asthma (Bronchial Asthma) 10/2021 - 11/2008
4	Inflammation (Inflammations) 01/2017 - 11/2008
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 04/2010
3	Rhinitis 01/2007 - 12/2002
2	Bullous Pemphigoid (Pemphigoid) 01/2022 - 01/2015
2	Allergic Rhinitis 10/2021 - 07/2014
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2020
2	Drug Hypersensitivity (Drug Allergy) 07/2003 - 05/2002
1	Purpura 01/2022
1	Cryopyrin-Associated Periodic Syndromes 01/2022
1	Erythema Multiforme 01/2022
1	Cutaneous Mastocytosis 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Wells syndrome 01/2022
1	Infections 09/2021
1	Sudden Infant Death (SID) 09/2021
1	Peanut Hypersensitivity (Peanut Allergy) 01/2021
1	Rupture 01/2021
1	Dust Mite Allergy 01/2019
1	Bites and Stings (Sting) 01/2018
1	Confusion (Bewilderment) 04/2015
1	Anaphylaxis (Anaphylactic Shock) 08/2013
1	Drug-Related Side Effects and Adverse Reactions 09/2012
1	Blister (Bulla) 03/2010
1	Edema (Dropsy) 11/2007

Drug/Important Bio-Agent (IBA)

21	Immunoglobulin E (IgE)IBA 10/2022 - 01/2003
21	AllergensIBA 01/2021 - 02/2002
11	lipid transfer protein (glycolipid transfer protein)IBA 01/2022 - 08/2003
11	Omalizumab (Xolair)FDA Link 01/2022 - 02/2014
10	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 05/2002
8	Pharmaceutical PreparationsIBA 11/2018 - 05/2002
6	Histamine Antagonists (Antihistamines)IBA 01/2022 - 01/2003
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
6	fibrin fragment D (D-dimer)IBA 12/2019 - 01/2010
6	AutoantibodiesIBA 12/2019 - 01/2003
6	Profilins (Profilin)IBA 01/2016 - 08/2003
6	Histamine (Histamine Dihydrochloride)FDA Link 09/2012 - 05/2002
6	Thrombin FDA Link 09/2012 - 05/2006
5	Immunoglobulin G (IgG)IBA 01/2022 - 07/2003
5	Thromboplastin (Tissue Factor)IBA 12/2018 - 03/2007
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 01/2003
3	Biological ProductsIBA 10/2021 - 09/2012
3	AntibodiesIBA 07/2021 - 05/2003
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2013
3	ragweed pollenIBA 01/2016 - 06/2009
3	Prothrombin (Factor II)IBA 01/2015 - 05/2006
3	IgE Receptors (Fc epsilon RI)IBA 04/2010 - 01/2003
3	LatexIBA 08/2006 - 08/2003
2	Antinuclear AntibodiesIBA 07/2021 - 11/2008
2	anti-IgE antibodiesIBA 12/2019 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015 - 01/2003
2	Cyclooxygenase 1IBA 03/2007 - 08/2006
2	EnzymesIBA 03/2007 - 02/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2006 - 05/2003
2	Food Additives (Food Additive)IBA 02/2004 - 12/2002
1	ParvalbuminsIBA 08/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Iodide Peroxidase (Deiodinase)IBA 01/2022
1	Monoclonal AntibodiesIBA 10/2021
1	mRNA VaccinesIBA 09/2021
1	VaccinesIBA 09/2021
1	COVID-19 VaccinesIBA 09/2021
1	LipidsIBA 01/2021
1	stable plasma protein solutionIBA 01/2021
1	CarbohydratesIBA 01/2021
1	LipocalinsIBA 01/2020
1	Serum AlbuminIBA 01/2020
1	LeguminsIBA 01/2019
1	Pyridinolcarbamate (P23)IBA 01/2019
1	Seed Storage ProteinsIBA 01/2019
1	AlbuminsIBA 01/2019
1	Thyroglobulin FDA Link 12/2018
1	Bee Venoms (Bee Venom)IBA 01/2018
1	hypoxanthine arabinoside (ara-H)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	AnticoagulantsIBA 01/2015
1	Protein Isoforms (Isoforms)IBA 09/2014
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 02/2014
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 09/2012
1	Peptide Hydrolases (Proteases)FDA Link 03/2010
1	Proteinase-Activated ReceptorsIBA 03/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2010
1	Tranexamic Acid (AMCA)FDA Link 01/2010
1	nascent-polypeptide-associated complexIBA 11/2008
1	AntigensIBA 11/2008
1	AutoantigensIBA 11/2008
1	Serine Proteases (Serine Protease)IBA 11/2007
1	Sodium Glutamate (Accent)IBA 01/2007

Therapy/Procedure

5	Immunotherapy 05/2021 - 06/2009
3	Therapeutics 01/2021 - 01/2003
3	Intradermal Injections 11/2008 - 05/2003
1	Contraindications 09/2021